Hemolab
Hemolab is a privately held Brazilian clinical laboratory in Rio Grande do Norte operating 15 collection units across Natal, Parnamirim, and São Gonçalo do Amarante, providing diagnostic testing across hematology, biochemistry, immunology, microbiology, and related specialties to individual patients and corporate clients.
- Company typePrivate
- Founded2023
- HeadquartersParnamirim, Brazil
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Hemolab does
Hemolab is a privately held Brazilian clinical laboratory founded in 1992 and headquartered in Natal, Rio Grande do Norte. The company operates a regional network of 15 physical collection units across Natal, Parnamirim, and São Gonçalo do Amarante, delivering diagnostic testing services across a broad specialty footprint that includes molecular biology, hematology, immunohematology, flow cytometry, biochemistry, immunology, hormones, urinalysis, parasitology, microbiology, and mycology. Hemolab positions itself as the pioneer clinical laboratory in Rio Grande do Norte to hold DICQ certification under the Sistema Nacional de Acreditação of the Sociedade Brasileira de Análises Clínicas, and it has maintained the PNCQ Excelência Laboratorial Diamond Category for 20 years of continuous quality performance.
The business model is fee-for-service clinical diagnostics, with revenue generated through individual patient payments, corporate wellness contracts, and — most importantly — billing against a network of 23+ Brazilian health insurance plans (convenios) including Amil, Bradesco, Unimed, Hapvida, SulAmerica, and Petrobras. Sample collection is delivered through multiple channels: in-unit phlebotomy at the 15 physical sites, drive-thru collection, at-home adult and pediatric collection, and on-site corporate collection. Digital infrastructure includes a Google Play-distributed mobile app for test-result retrieval and unit location, a web-based results portal (Pulse Saúde), and an s2medica-powered online checkout for purchasing laboratory services directly.
Hemolab employs between 11 and 50 staff and competes as a regional incumbent against larger national diagnostic networks. Its commercial positioning rests on local brand recognition established over three decades, formal quality accreditations, multi-channel convenience (including differentiated drive-thru and home-collection services), and dense physical coverage across the Greater Natal metropolitan area. There is no disclosed funding history, M&A activity, public-market presence, or leadership turnover in the source data; the company operates as an independent private regional diagnostic provider concentrated in a single Brazilian state.
Hemolab firmographics
Firmographics- Name
- Hemolab
- Legal name
- Hemolab
- Website
- https://hemolabrn.com.br
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hemolab is a privately held Brazilian clinical laboratory in Rio Grande do Norte operating 15 collection units across Natal, Parnamirim, and São Gonçalo do Amarante, providing diagnostic testing across hematology, biochemistry, immunology, microbiology, and related specialties to individual patients and corporate clients.
- Ownership category
- akta.pro rank
Hemolab industry classification
Industry- Product category
- Clinical Laboratory Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
- akta.pro secondary industries
- Hematology & Coagulation Laboratories (HLAFAMAC), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Hematology & Coagulation Diagnostics (HLAHAAAB)
Keywords
Where Hemolab is headquartered
LocationHeadquarters
- HQ city
- Parnamirim
- HQ country
- Brazil
- HQ region
- Latin America
Offices15 records
Markets served
Hemolab business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Clinical Laboratory Services: Revenue generated from diagnostic testing services performed at laboratory locations and through home/corporate collection. Services are billed through health insurance plans (convenios) and direct patient payments.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
Hemolab product offering
Product offeringCore offering
Hemolab is a clinical analysis laboratory operating 15 physical units across Rio Grande do Norte, Brazil, providing comprehensive diagnostic testing services spanning molecular biology, hematology, immunohematology, flow cytometry, biochemistry, immunology, hormones, urinalysis, parasitology, microbiology, and mycology. The laboratory supplements its in-facility services with home and corporate sample collection, drive-thru testing, and digital access to results via a mobile app and online portal.
Product overview
Hemolab is a clinical analysis laboratory operating as a single unified service provider in Rio Grande do Norte, Brazil. The company offers comprehensive diagnostic services across multiple specialty areas including molecular biology, hematology, flow cytometry, biochemistry, immunology, and microbiology, utilizing high-technology automation equipment. Services are delivered through 15 physical locations throughout Natal and Parnamirim, supplemented by home collection, corporate collection, and drive-thru options. Digital access is provided via a mobile app for result retrieval and unit location, along with an online shopping platform for purchasing services.
Differentiator
Problem solved
Functional benefit
Products and services
- Laboratory Clinical Analysis Services Comprehensive clinical diagnostic testing spanning molecular biology, hematology, immunohematology, flow cytometry, biochemistry, immunology, hormones, urinalysis, parasitology, microbiology, and mycology. Performed at Hemolab's 15 physical units for individual patients covered by health insurance (convenios) or paying directly.
- Home and Corporate Collection (Coleta Domiciliar e Empresarial) At-home and on-site corporate sample collection performed by specialized phlebotomy staff for adult and pediatric patients, intended for individuals who cannot visit a unit and for companies running employee health screenings or wellness programs.
- Drive-Thru Sample Collection Drive-through sample collection point at Hemolab locations that lets patients provide samples without leaving the vehicle, using high-technology equipment with professional staff.
- Hemolab Mobile App Mobile application for Hemolab patients to access their laboratory test results, find the nearest Hemolab unit, and obtain additional service information, complementing the in-lab and home collection services.
- Online Results Portal Web-based portal that allows patients to retrieve Hemolab laboratory test results online through the pulsesaude.com.br platform.
- Online Service Purchasing Online purchasing channel on the s2medica platform where customers can buy Hemolab laboratory services directly.
Companies that use Hemolab
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles2 records
Hemolab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Hemolab partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Hemolab competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Hemolab social profiles
Digital presenceHemolab compliance and trust
Trust signalCompliance2 records
Hemolab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hemolab leadership team
Management profileNumber of profiles
Hemolab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hemolab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hemolab
What does Hemolab do?
Hemolab is a clinical analysis laboratory operating 15 physical units across Rio Grande do Norte, Brazil, providing comprehensive diagnostic testing services spanning molecular biology, hematology, immunohematology, flow cytometry, biochemistry, immunology, hormones, urinalysis, parasitology, microbiology, and mycology. The laboratory supplements its in-facility services with home and corporate sample collection, drive-thru testing, and digital access to results via a mobile app and online portal.
Is Hemolab a public or private company?
Hemolab is a private company. It is classified as unknown and is currently operating.
When was Hemolab founded?
Hemolab was founded in 2023. It employs 11 to 50 people.
Where is Hemolab based?
Hemolab is headquartered in Parnamirim, Brazil, in the Latin America region.
How does Hemolab make money?
One revenue line is on record: clinical Laboratory Services.
Does Hemolab have an API?
No public API is recorded for Hemolab.
What industry is Hemolab in?
Hemolab's product category is Clinical Laboratory Diagnostics. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAFAMAC, Hematology & Coagulation Laboratories. Its NAICS code is 621511 and its SIC code is 8071.